This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
MMSI vs. ALGN: Which Stock Is the Better Value Option?
by Zacks Equity Research
MMSI vs. ALGN: Which Stock Is the Better Value Option?
MMSI vs. ALGN: Which Stock Is the Better Value Option?
by Zacks Equity Research
MMSI vs. ALGN: Which Stock Is the Better Value Option?
Lamb Weston and Align Technology have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Lamb Weston and Align Technology have been highlighted as Zacks Bull and Bear of the Day.
Bear of the Day: Align Technology, Inc. (ALGN)
by Benjamin Rains
Align now faces tough-to-compete against periods and a rapid slowdown in consumer spending. The company fell short of Q3 estimates in late October and its earnings outlook is fading alongside its stock price.
Align Technology (ALGN) Q3 Earnings Lag Estimates, Margins Drop
by Zacks Equity Research
The volatility surrounding inflationary pressure, weaker consumer confidence and the lingering impacts of COVID-19 shutdowns continue to pose challenges for Align Technology (ALGN).
Align Technology (ALGN) Misses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of -38.46% and 8.11%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
West Pharmaceutical Services (WST) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
West Pharmaceutical (WST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Align Technology (ALGN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) to Post Q3 Earnings: What's in Store?
by Zacks Equity Research
Align Technology's (ALGN) Invisalign First for kids is gaining market share rapidly across all regions.
DexCom and Papa John's International have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
DexCom and Papa John's International are part of the Zacks Bull and Bear of the Day article.
3 Stocks From the Growing Digital Orthodontic Space in Focus
by Urmimala Biswas
The orthodontic treatment market has experienced substantial recovery, primarily owing to the easing of restrictions and mass opening up of the economy in 2022.
Implied Volatility Surging for Align Technology (ALGN) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Align Technology (ALGN) stock based on the movements in the options market lately.
New Strong Sell Stocks for September 27th
by Zacks Equity Research
ALGN, CNA and DH have been added to the Zacks Rank #5 (Strong Sell) List on September 27, 2022.
Align Technology (ALGN) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $245.74 in the latest trading session, marking a +0.84% move from the prior day.
Align Technology (ALGN) Q2 Earnings Lag Estimates, Margins Drop
by Zacks Equity Research
The dull underlying market situation, impacted by macro-economic environmental factors and lingering effects of COVID-19 variants in certain markets, impacts Align Technology's (ALGN) Q2 results.
Align Technology (ALGN) Q2 Earnings and Revenues Miss Estimates
by Zacks Equity Research
Align Technology (ALGN) delivered earnings and revenue surprises of -5.66% and 0.57%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
MedTech Stocks' Earnings Due on Jul 27: BSX, HOLX & ALGN
by Urmimala Biswas
MedTech companies' results are likely to reflect a rebound in the base business. Let's see how BSX, HOLX and ALGN fare this time.
BDX or ALGN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BDX vs. ALGN: Which Stock Is the Better Value Option?
Earnings Preview: Align Technology (ALGN) Q2 Earnings Expected to Decline
by Zacks Equity Research
Align Technology (ALGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Align Technology (ALGN) Stock Moves -0.31%: What You Should Know
by Zacks Equity Research
In the latest trading session, Align Technology (ALGN) closed at $254.08, marking a -0.31% move from the previous day.
Align Technology (ALGN) to Post Q2 Earnings: What's in Store?
by Zacks Equity Research
Strong Invisalign adoption and continued growth in the iTero scanner installed base are likely to have driven Align Technology's (ALGN) Q2 performance.
Align Technology (ALGN) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed the most recent trading day at $248.98, moving -0.2% from the previous trading session.
BDX vs. ALGN: Which Stock Is the Better Value Option?
by Zacks Equity Research
BDX vs. ALGN: Which Stock Is the Better Value Option?
Align Technology (ALGN) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Align Technology (ALGN) closed at $249.54 in the latest trading session, marking a -1.8% move from the prior day.
3 Top Stocks to Buy in July and Hold for Long-Term Growth
by Benjamin Rains
The current uncertainty and bearish sentiment from many on Wall Street might offer investors a chance to start positions in fantastic stocks at nice entry points. The three stocks we explore today are Align Technology, Inc. (ALGN), Mastercard (MA), and Intuit (INTU).